Skip to main content
. 2022 Jan 14;17(1):e0262315. doi: 10.1371/journal.pone.0262315

Table 2. Patient characteristics by type of ventilation.

Invasive ventilation only (IMV) Non-invasive ventilation only (NIV) Non-invasive ventilation failure (NIV-F) Non-invasive ventilation failure by day of failure
First day Second day Third or fourth day Fifth day or later
Number of patients 7235 4469 3472 1213 591 684 984
Age (years)
Mean (SD) 68.0 (12.9) 71.2 (13.5) 68.6 (11.9) 67.9 (12.5) 68.6 (12.3) 68.9 (11.4) 69.1 (11.0)
Median (IQR) 70.0 (60.0, 78.0) 74.0 (62.0, 82.0) 70.0 (62.0, 78.0) 69.0 (60.0, 78.0) 70.0 (61.0, 78.0) 71.0 (62.0, 78.0) 70.0 (62.0, 78.0)
18–49 years 613 (8.5%) 325 (7.3%) 228 (6.6%) 101 (8.3%) 42 (7.1%) 38 (5.6%) 47 (4.8%)
50–59 years 1,095 (15.1%) 541 (12.1%) 470 (13.5%) 176 (14.5%) 78 (13.2%) 88 (12.9%) 128 (13.0%)
60–69 years 1,904 (26.3%) 886 (19.8%) 996 (28.7%) 336 (27.7%) 173 (29.3%) 197 (28.8%) 290 (29.5%)
70–79 year 2,135 (29.5%) 1,131 (25.3%) 1,102 (31.7%) 358 (29.5%) 178 (30.1%) 230 (33.6%) 336 (34.1%)
≥ 80 years 1,488 (20.6%) 1,586 (35.5%) 676 (19.5%) 242 (20.0%) 120 (20.3%) 131 (19.2%) 183 (18.6%)
Male 4,687 (64.8%) 2,725 (61.0%) 2,405 (69.3%) 816 (67.3%) 418 (70.7%) 475 (69.4%) 696 (70.7%)
Female 2,548 (35.2%) 1,744 (39.0%) 1,067 (30.7%) 397 (32.7%) 173 (29.3%) 209 (30.6%) 288 (29.3%)
Elixhauser comorbidities
Hypertension 4,913 (67.9%) 3,129 (70.0%) 2,482 (71.5%) 839 (69.2%) 428 (72.4%) 476 (69.6%) 739 (75.1%)
Diabetes 3,182 (44.0%) 1,889 (42.3%) 1,556 (44.8%) 543 (44.8%) 258 (43.7%) 302 (44.2%) 453 (46.0%)
Cardiac arrhythmias 3,304 (45.7%) 1,619 (36.2%) 1,641 (47.3%) 557 (45.9%) 290 (49.1%) 327 (47.8%) 467 (47.5%)
Renal failure 2,006 (27.7%) 1,430 (32.0%) 931 (26.8%) 323 (26.6%) 172 (29.1%) 185 (27.0%) 251 (25.5%)
Congestive heart failure 2,494 (34.5%) 1,510 (33.8%) 1,195 (34.4%) 398 (32.8%) 212 (35.9%) 238 (34.8%) 347 (35.3%)
Chronic pulmonary disease 1,351 (18.7%) 950 (21.3%) 716 (20.6%) 230 (19.0%) 118 (20.0%) 151 (22.1%) 217 (22.1%)
Obesity 1,220 (16.9%) 610 (13.6%) 624 (18.0%) 232 (19.1%) 111 (18.8%) 126 (18.4%) 155 (15.8%)
Charlson comorbidity index: 0 1,192 (16.5%) 953 (21.3%) 613 (17.7%) 226 (18.6%) 109 (18.4%) 115 (16.8%) 163 (16.6%)
Charlson comorbidity index: 1 1,479 (20.4%) 959 (21.5%) 722 (20.8%) 252 (20.8%) 104 (17.6%) 151 (22.1%) 215 (21.8%)
Charlson comorbidity index: 2 1,179 (16.3%) 725 (16.2%) 620 (17.9%) 220 (18.1%) 107 (18.1%) 124 (18.1%) 169 (17.2%)
Charlson comorbidity index: 3–4 1,854 (25.6%) 1,050 (23.5%) 890 (25.6%) 319 (26.3%) 157 (26.6%) 185 (27.0%) 229 (23.3%)
Charlson comorbidity index: ≥ 5 1,531 (21.2%) 782 (17.5%) 627 (18.1%) 196 (16.2%) 114 (19.3%) 109 (15.9%) 208 (21.1%)
Patients transferred between hospitals 2,963 (41.0%) 800 (17.9%) 1,397 (40.2%) 501 (41.3%) 228 (38.6%) 267 (39.0%) 401 (40.8%)
Length of hospital stay (days)
Mean (SD) 41.5 (40.1) 20.4 (16.8) 37.6 (33.6) 35.6 (32.3) 35.6 (32.0) 34.7 (29.9) 43.2 (37.7)
Median (IQR) 29.0 (16.0, 53.5) 16.0 (10.0, 26.0) 27.0 (16.0, 47.0) 26.0 (15.0, 45.0) 26.0 (16.0, 44.5) 25.0 (15.0, 44.2) 30.0 (19.0, 54.0)
Ventilation (days)
Mean (SD) 19.0 (19.2) 4.1 (4.7) 21.6 (20.2) 20.1 (19.5) 20.6 (19.5) 21.5 (20.3) 24.2 (21.3)
Median (IQR) 13.3 (6.3, 25.1) 2.7 (1.2, 5.3) 15.8 (9.2, 27.5) 14.3 (8.2, 25.7) 15.5 (8.9, 25.3) 15.6 (9.3, 26.4) 18.0 (10.5, 31.0)
Tracheostomy 2,705 (37.4%) 0 (0.0%) 1,312 (37.8%) 437 (36.0%) 216 (36.5%) 256 (37.4%) 403 (41.0%)
ECMO 616 (8.5%) 14 (0.3%) 479 (13.8%) 155 (12.8%) 71 (12.0%) 90 (13.2%) 163 (16.6%)
Dialysis 2,130 (29.4%) 257 (5.8%) 1,188 (34.2%) 396 (32.6%) 201 (34.0%) 240 (35.1%) 351 (35.7%)
In-hospital mortality 3,874 (53.5%) 1,949 (43.6%) 2,306 (66.4%) 746 (61.5%) 382 (64.6%) 470 (68.7%) 708 (72.0%)

ECMO = extracorporeal membrane oxygenation, NIV = non-invasive ventilation, NIV-F = non-invasive ventilation failure.